CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

About

Brief Summary

Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.

Study Type

Observational

Eligibility

Gender

All

Minimum Age

18 Years

Maximum Age

N/A

Inclusion Criteria:

A subject must meet all the following criteria to participate in the registry:
- Has been diagnosed with alopecia areata by a dermatologist or a qualified dermatology practitioner.
- Is at least 18 years of age or older.
- Is willing to provide Personal Information.
- Is prescribed or starting an Enrollment Eligible Medication at the time of enrollment.

Exclusion Criteria:

Any of the following would exclude the subject from participating in the registry:
- Is participating or planning to participate in a double-blind randomized trial for an AA drug. Note: Concurrent participation in another observational registry or open-label Phase 3b/4 trial is allowed.

Not a fit? Find another study